104 related articles for article (PubMed ID: 3762917)
1. Rate of clearance of intrathecal iopamidol in the dog.
Wilcox J; Evill CA; Sage MR
Neuroradiology; 1986; 28(4):359-61. PubMed ID: 3762917
[TBL] [Abstract][Full Text] [Related]
2. Brain parenchyma penetration by intrathecal nonionic iopamidol.
Sage MR; Wilcox J
AJNR Am J Neuroradiol; 1983; 4(6):1181-3. PubMed ID: 6419558
[TBL] [Abstract][Full Text] [Related]
3. Brain penetration of intrathecal iomeprol in dogs.
La Noce A; Lorenzon P; Pugliese F; Pellecchi G; Orlandini I; Tirone P
Acta Radiol; 1996 Jul; 37(4):578-81. PubMed ID: 8688246
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of lopamidol after intrathecal administration in humans.
Duchin KL; Drayer BP; Ross M; Allen S; Frantz M
AJNR Am J Neuroradiol; 1986; 7(5):895-8. PubMed ID: 3096110
[TBL] [Abstract][Full Text] [Related]
5. Iopamidol for intrathecal use in pediatric neuroradiology.
Ruggiero R; Piscitelli G; Ambrosio A
Acta Radiol Suppl; 1986; 369():532-6. PubMed ID: 2980550
[TBL] [Abstract][Full Text] [Related]
6. Penetration of the brain by nonionic water soluble tri- and hexaiodinated contrast media. Experimental autoradiographic study of two contrast media: Iotrol and Iopamidol labelled with iodine 125.
Castel JC; Dorcier F; Caillé JM
Neuroradiology; 1987; 29(2):206-10. PubMed ID: 3587597
[TBL] [Abstract][Full Text] [Related]
7. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
Broadbridge AT; Bayliss SG; Firth R; Farrell G
Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
[TBL] [Abstract][Full Text] [Related]
8. An experimental evaluation of response to contrast media: Pantopaque, iopamidol, and iohexol in the subarachnoid space.
Paşaoğlu A; Gök A; Patiroğlu TE
Invest Radiol; 1988 Oct; 23(10):762-6. PubMed ID: 3192397
[TBL] [Abstract][Full Text] [Related]
9. Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.
Beltramello A; Leonardi M; Biasizzo E; Piscitelli G
Acta Radiol Suppl; 1986; 369():542-4. PubMed ID: 2980553
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal administration of iopamidol in children: clinical and diagnostic results.
Wells RG; Seidel FG; Sty JR; Swick HM
Pediatr Radiol; 1988; 18(3):190-3. PubMed ID: 3368243
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicologic effects of the nonionic contrast agent iopamidol on the leptomeninges of the dog.
Spencer CP; Chrisman CL; Mayhew IG; Kaude JV
Am J Vet Res; 1982 Nov; 43(11):1958-62. PubMed ID: 6891192
[TBL] [Abstract][Full Text] [Related]
12. [Intrathecal roentgen contrasting--experiences with iopamidol].
Stellamor V; Stellamor K; Perneczky G
Rontgenpraxis; 1984 Jun; 37(6):213-9. PubMed ID: 6548320
[No Abstract] [Full Text] [Related]
13. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
Vézina JL; Fox AJ
J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
[TBL] [Abstract][Full Text] [Related]
14. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
Hammer B
Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
[TBL] [Abstract][Full Text] [Related]
15. Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
Lexmaulova L; Zatloukal J; Proks P; Dvorak M; Srnec R; Rauser P; Kecova H; Necas A
J Vet Emerg Crit Care (San Antonio); 2009 Dec; 19(6):611-6. PubMed ID: 20017767
[TBL] [Abstract][Full Text] [Related]
16. Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.
Hammer B; Deisenhammer E
Neuroradiology; 1985; 27(4):337-41. PubMed ID: 3900800
[TBL] [Abstract][Full Text] [Related]
17. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media.
Oi H; Yamazaki H; Matsushita M
Radiat Med; 1997; 15(1):23-7. PubMed ID: 9134581
[TBL] [Abstract][Full Text] [Related]
18. Lumbar myelography with iopamidol: a methodological approach to the investigation of side effects.
Provinciali L; Signorino M; Giovagnoli AR; Baroni M; Angeleri F; Salvolini U; Pasquini U; Porta M; Judice A; Cerutti R
Neuroradiology; 1988; 30(6):528-33. PubMed ID: 3226540
[TBL] [Abstract][Full Text] [Related]
19. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity of iohexol vs iopamidol in lumbar myelography. Clinical, electrophysiological and brain CT scan correlations.
Floras P; Deliac P; Gross C; Jouet P; Paty J; Caille JM
J Neuroradiol; 1990; 17(3):190-200. PubMed ID: 2286841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
